Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine added to steroids for relapse of pediatric nephrotic syndrome
IRCT20201112049368N2Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levothyroxine sodium and prednisolone in nephrosis (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Time to improvement of relapse. Started Nov 2022; status: completed.
02
Drugs
levothyroxine sodiumprednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on IRCT20201112049368N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201112049368N2.